Company Insider Tape

Monte Rosa Therapeutics Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol GLUE Latest filing 16 Jul 2026

Company Read

Net disposal

GLUE has 61 stored insider filings. Acquisitions account for 37.7% of classified filings and disposals account for 62.3%. The largest stored filing is $642.7K from JANKU, FILIP.

Latest filing 16 Jul 2026most recent stored row
Largest filing $642.7Kreported transaction value
Total filings 61stored transaction rows
Acquisition value $635.7K23 acquisitions
Disposal value $2.8M38 disposals
Net value $-2.1Macquisitions minus disposals

Filing cadence

Last 12 active months
Apr 2026 1
May 2026 13
Jun 2026 36
Jul 2026 11

Acquisitions 37.7% · Disposals 62.3%

Apr 2026 $141.1K
May 2026 $583.4K
Jun 2026 $2.2M
Jul 2026 $516.0K

Executive concentration

By filing count
CHAMPOUX, JENNIFER Chief Operating Officer · 15 filings
TOWNSON, SHARON Chief Scientific Officer · 13 filings
JANKU, FILIP Chief Medical Officer · 12 filings
MANNING, ANTHONY M. Director · 7 filings
WARMUTH, MARKUS Director, President & CEO · 5 filings
BEHBAHANI, ALI Director · 4 filings
HUGHES, ERIC A Director · 1 filings
SCHIFF, ANDREW N Director · 1 filings

Market Context

GLUE weekly market snapshot

Week 31 Jul 2026
Latest close 16.52 USDstored weekly close
1-week move -27.5%latest weekly bar
13-week move -31.8%medium-term context
Relative Strength -2.4Sharemaestro indicator
Fair value gap +85.9%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for GLUE

Showing 61-61 of 61
Date 14 Apr 2026
Insider WARMUTH, MARKUSDirector, President & CEO
Side Disposal
Shares 8000
Price 17.64
Value 141125
Security Common Stock